Turn-based RPGs aren't for everyone, and that has become even more true in the modern age of gaming and digital media. These days, it only takes a few seconds for someone to decide whether a video on ...
Josh Cotts is a Senior Contributor at GameRant. He graduated Summa Cum Laude from Arizona State University in 2019 with a B.A. in Mass Communications & Media Studies and has been recognized for his ...
Nowadays, JRPGs are making a powerful comeback to the mainstream. And while I say mainstream, I mean game events, community discussions, and even impressive sales numbers. However, in the process of ...
Developer Equalizer has announced retro pixel-style turn-based RPG, Mythic Yi, for the Nintendo Switch and PC via Steam. It will launch in 2026. View the announcement trailer below: Read details on ...
Sovereign Tea is yours to keep on Steam. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.
Tristan Jurkovich began his career as a journalist in 2011. His childhood love of video games and writing fuel his passion for archiving this great medium’s history. He dabbles in every genre, but ...
Announced a few months ago, Star Sailors is now opening its doors for pre-registration. The new gacha game doesn’t have a concrete release date, but according to the Apple App Store, it’s expected on ...
While XCOM 3 remains a pipedream for now, there are an increasing number of tactical RPGs ready to step up to the empty half-cover and take their shot. Among them, Menace is one I've had a ...
When you pick up your phone today, you probably tap an icon before you even think about it, where native apps dominate your ...
The Tory leader says the student loan system is at "breaking point" as the PM says his government will "look at ways to make it fairer".
The characters from Marvel Comics are the inspirations for many stellar games, from Marvel Rivals and Marvel’s Ultimate Alliance. Superhero team-ups like these titles provide great co-op experiences, ...
Atara Biotherapeutics (ATRA) stock jumps as an FDA top official reportedly overruled internal reviewers in rejecting the company's cell therapy. Read more here.